Enables microtubule binding activity. Involved in several processes, including axonal transport; positive regulation of insulin secretion involved in cellular response to glucose stimulus; and regulation of synaptic activity. Acts upstream of or within regulation of insulin secretion involved in cellular response to glucose stimulus. Located in dense body; microtubule; and vesicle. Orthologous to human SYBU (syntabulin); PARTICIPATES IN mitochondria transport pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol; bisphenol A.
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYBU mRNA
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYBU mRNA
[Estradiol co-treated with Progesterone] results in increased expression of SYBU mRNA and [Progesterone co-treated with Estradiol] results in increased expression of SYBU mRNA
[Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of SYBU mRNA and [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of SYBU mRNA
[Tamoxifen co-treated with ESR1 protein] results in increased expression of SYBU mRNA and [Tamoxifen co-treated with ESR2 protein] results in decreased expression of SYBU mRNA
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYBU mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYBU mRNA